President & Immunovant CEO
Wed, Oct 8, 2025
Oct 8
128,295 shares @ $7.45
Increased holdings by +8.50%
80th largest trade (out of 285)
Trade made by an officer
10b5-1 scheduled trade
39% win rate · -2.2% median edge vs SPY (70 trades, 90-day)
Insider trade was 54% below market price
Price 39% above 200-day moving average